Skip to main content
MPT logo

MPT · Medical Properties Trust Inc

Track MPT — free
Market Cap
$2.42B
Shares
598.10M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.01 Open$4.04 Day$3.96–4.08 52W close$3.97–6.02 Avg vol 30d7.7M Short int144.5M · 24.2% float · 15.6d Short vol78% Last earningsAug 10, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 15, 2026 Est · unconfirmed · in 10 wks
filed Aug 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.00B
Trailing 12 months
Net income (TTM)
−$126.24M
Trailing 12 months
Revenue growth YoY
+12.6%
Year over year
Operating margin
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
−$9.24B
Latest balance sheet
Dividend yield
8.7%
Trailing 12 months
Shares change YoY
-0.5%
Year over year · fewer shares
Price change (1Y)
-9.9%
Trailing year
Short interest
24.2%
Latest settlement · 15.6 days to cover
View all 114 metrics

AI Brief

Q2 FY26 earnings call · Aug 10, 2026
Q2 FY26

TL;DR. MPT announced a $2.4 billion 9.25% secured refinancing that eliminates 2026 maturities and materially reduces 2027 unsecured maturities, with no debt due until June 2028; portfolio coverage remains broadly stable with post-acute EBITDA up over $70 million YoY and NFFO of $0.15 in line with expectations, while behavioral health coverage slipped to 1.4x and U.K. NHS funding pressure persists.

Bullish
  • + Announced $2.4 billion refinancing extends $2.4 billion of debt maturities to 2032 with no debt maturing in 2026 or 2027.
  • + Refinancing reduces total principal debt by approximately $123 million and substantially increases UA/UD covenant headroom to up to nearly 300%.
  • + Post-acute portfolio EBITDA increased more than $70 million YoY, led by 24% growth in Median and 13% in Ernest Health, with 2.4x coverage.
  • + Asset sales validate market values materially above book, including a pending $172 million sale at a 60%+ gain over original investment and 34% IRR.
Bearish
  • Behavioral health coverage slipped to 1.4x due to U.K. NHS funding pressures and is a source of pressure on the overall portfolio.
  • HSA cash collections remain below target (still in the 80s), with a Meditech EMR conversion, RCM outsourcing disruption, and delayed Florida supplemental funding pressuring liquidity.
  • Secured debt ratio is rising to near the 40% covenant ceiling, limiting additional secured-debt capacity absent asset sales.
  • Company impaired approximately $17 million in working capital loans tied to Steward replacement tenants in the Midwest.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Moderate
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −19%
below
Price vs 50-day avg −10%
below
RSI (14) 38
neutral
MACD trend Positive
52-week position 2%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −15%
trailing
6-month return −16%
trailing
YTD return −20%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Distributing
-2% holders QoQ · +52 funds added
Insider flow Accumulating
Net +$9.5K over 90 days · 0% sells
Short interest Rising
24.16% of float · ▲ +0.2% MoM · 15.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
496 holders — mid 3-yr range
Squeeze score 74
high risk · 0–100
Fundamentals
Fair
Revenue growth −2%
Y/Y
EPS growth +89%
Y/Y
Buyback $150.0M
authorized
Balance sheet $9.2B
net debt
Quant / Vol
risk profile
Moderate
Volatility 38%
annualized · 1-yr
Max drawdown −34%
past year
ATR 3.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−19% Bearish
Price vs 50-day avg
−10% Bearish
RSI (14)
38 Neutral
MACD trend
Positive Bullish
52-week position
2% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Distributing
-2% holders QoQ · +52 funds added
Insider flow Accumulating
Net +$9.5K over 90 days · 0% sells
Short interest Rising
24.16% of float · ▲ +0.2% MoM · 15.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
496 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4 Now $4 · 2% Range high $6
vs 200-day avg -19% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MPT
Medical Properties Trust Inc
this stock
$2.42B -19.8% -2.4% 24.2%
WELL
Welltower Inc.
$170.21B +27.2% +35.6% 120.0 2.5%
VTR
Ventas, Inc.
$47.25B +16.7% +18.5% 170.6 4.6%
DOC
Healthpeak Properties, Inc.
$14.50B +28.4% +4.5% 60.1 3.3%
OHI
Omega Healthcare Investors Inc
$14.25B +4.6% +13.2% 16.7 4.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
496
% held
64.2%
Net QoQ
+14.7M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
252
View
Short & Settlement
Short Interest Rising
Shares short
144.5M
Days to cover
15.6d
Change
+227.9K sh
View
Short Volume
Short vol %
78%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
40.2K
Value
$162.7K
As of
Aug 13, 2026
View
Off-Exchange
Off-exchange %
45.4%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$9.5K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Congressional Trades Sell
Member
Pete Sessions
Amount
$257–$257
Traded
Nov 3, 2023
View
Financials
Financials
Revenue (FY)
$972.0M
Net income (FY)
$-277.0M
EPS diluted
$-0.46
View
Buybacks
Authorized
$150.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 10, 2026
This year
10
View
Proposed Sales
Value
$300.9K
Shares
59.0K
Filed
Nov 19, 2025
View
Earnings & Events
Earnings Calls
Last call
Aug 10, 2026
View
Investor Relations
Latest news
MPT Declares Regular Quarterly Di…
Published
Aug 13, 2026
View

Performance

5D 20D 120D MTD YTD
MPT -2.0% -14.7% -16.1% +1.0% -19.8%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -2.1% -14.3% -31.2% +0.6% -32.7%

Capital returns

Latest dividend
$0.09 / share · ex Jun 18, 2026
Declared · upcoming
$0.09 / share · ex Sep 10, 2026
Raised 12.5%
Paid (TTM)
$0.35 / share · 4 payouts
Dividend yield (TTM, derived)
8.73%
Buyback program · as of Oct 28, 2025
Authorized
$150.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1287865 CUSIP 58463J304 13F (30d) 326 filings 306 filers Visit website Investor relations